Fact CheckerSign in

NCT06745609Active, not recruiting

Prehabilitation Prior to Surgery for Kidney Tumors

Prehabilitation Prior to Surgery for Kidney Tumors: A Randomized Controlled Research Study (Pre-KiT)

Source: ClinicalTrials.gov · Last updated 2 Sept 2026

Brief summary (registry, in English)

The goal of this clinical trial is to examine if one month of general health optimization before surgery for kidney tumors can help participants recover more quickly from surgery. The optimization process is called prehabiliation, and will last one month. It consists of 1. A comprehensive health assessment 2. Assisted smoking cessation 3. A home exercise program. The investigators will compare an intervention group receiving one month of prehabilitation with a control group receiving the standard of care. Some of the main questions the investigators want to answer are * Are participants in the intervention group more satisfied with their quality of recovery after surgery? * Do participants in the intervention group maintain more of their physical abilites compared to the control group?

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
12 Dec 2024
Start date
21 Jan 2025
Primary completion date
1 Jun 2026
Lead sponsor
Herlev and Gentofte Hospital
NCT number
NCT06745609

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 21 Jan 2025 to the primary completion date, 1 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • It is determined by an attending physician, or at a multi-disciplinary team-conference, that a 2-4 week postponement of surgery will not be beneficial for the participant.

Other

  • Participant does not understand Danish og English

Who the study is looking for

  • 65 years or older
  • cT1 kidney tumor, scheduled for either partial or radical nephrectomy.
  • Clinical Frailty Scale 3-6

Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Urology, Herlev and Gentofte Hospital
Coordinator of this site? Confirm its status
HerlevDenmarkUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.